Literature DB >> 11641388

Selected contribution: Gender differences in the endothelin-B receptor contribution to basal cutaneous vascular tone in humans.

D L Kellogg1, Y Liu, P E Pérgola.   

Abstract

To test whether the contribution of endothelin-B (ET-B) receptors to resting vascular tone differs between genders, we administered the ET-B receptor antagonist BQ-788 into the forearm skin of 11 male and 11 female subjects by intradermal microdialysis. Skin blood flow was measured using laser-Doppler flowmetry at the microdialysis site. The probe was perfused with Ringer solution alone, followed by BQ-788 (150 nM) and finally sodium nitroprusside (28 mM) to effect maximal cutaneous vasodilation. Cutaneous vascular conductance (CVC) was calculated (laser-Doppler flowmetry/mean arterial pressure) and normalized to maximal levels (%max). In male subjects, baseline CVC was (mean +/- SE) 19 +/- 3%max and increased to 26 +/- 5%max with BQ-788 (P < 0.05 vs. baseline). In female subjects, baseline CVC was 13 +/- 1%max and decreased to 10 +/- 1%max in response to BQ-788. CVC responses to BQ-788 differed with gender (P < 0.05); thus the contribution of ET-B receptors to resting cutaneous vascular tone differs between men and women. In men, ET-B receptors mediate tonic vasoconstriction, whereas, in women, ET-B receptors mediate tonic vasodilation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11641388     DOI: 10.1152/jappl.2001.91.5.2407

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  25 in total

1.  Double injection vs skin microdialysis technique in minimally invasive in vivo pharmacology.

Authors:  Pawan K Rao; Pablo E Pérgola; Nusrath M Habiba; Y Liu; Dean L Kellogg
Journal:  Br J Clin Pharmacol       Date:  2002-09       Impact factor: 4.335

Review 2.  Chronic orthostatic intolerance and the postural tachycardia syndrome (POTS).

Authors:  Julian M Stewart
Journal:  J Pediatr       Date:  2004-12       Impact factor: 4.406

3.  Intradermal administration of endothelin-1 attenuates endothelium-dependent and -independent cutaneous vasodilation via Rho kinase in young adults.

Authors:  Naoto Fujii; Tatsuro Amano; Lyra Halili; Jeffrey C Louie; Sarah Y Zhang; Brendan D McNeely; Glen P Kenny
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-11-23       Impact factor: 3.619

4.  Pharmacological curve fitting to analyze cutaneous adrenergic responses.

Authors:  Megan M Wenner; Thad E Wilson; Scott L Davis; Nina S Stachenfeld
Journal:  J Appl Physiol (1985)       Date:  2011-08-25

5.  Endothelin B receptor contribution to peripheral microvascular function in women with polycystic ovary syndrome.

Authors:  Megan M Wenner; Hugh S Taylor; Nina S Stachenfeld
Journal:  J Physiol       Date:  2011-08-08       Impact factor: 5.182

6.  Alterations in endothelin type B receptor contribute to microvascular dysfunction in women who have had preeclampsia.

Authors:  Anna E Stanhewicz; Sandeep Jandu; Lakshmi Santhanam; Lacy M Alexander
Journal:  Clin Sci (Lond)       Date:  2017-11-23       Impact factor: 6.124

7.  ETB receptor contribution to vascular dysfunction in postmenopausal women.

Authors:  Megan M Wenner; Kelly N Sebzda; Andrew V Kuczmarski; Ryan T Pohlig; David G Edwards
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-04-24       Impact factor: 3.619

8.  Sex differences in thermal pain sensitivity and sympathetic reactivity for two strains of rat.

Authors:  Charles J Vierck; Antonio J Acosta-Rua; Heather L Rossi; John K Neubert
Journal:  J Pain       Date:  2008-05-16       Impact factor: 5.820

Review 9.  Endothelin, sex, and pregnancy: unique considerations for blood pressure control in females.

Authors:  Ellen E Gillis; Jennifer M Sasser; Jennifer C Sullivan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-03-02       Impact factor: 3.619

Review 10.  Role of the endothelin system in sexual dimorphism in cardiovascular and renal diseases.

Authors:  Eman Y Gohar; Fernanda R Giachini; David M Pollock; Rita C Tostes
Journal:  Life Sci       Date:  2016-03-03       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.